Quantcast

Latest Latent autoimmune diabetes Stories

2011-07-14 13:51:00

TAMPA, Fla., July 14, 2011 /PRNewswire-USNewswire/ -- In an effort to raise awareness of the effects of excess weight on overall health, the OAC has released a new series of educational brochures. Millions of Americans are affected by excess weight, obesity and severe obesity. One of the most common conditions related to excess weight is type 2 diabetes. Approximately 25.8 million Americans have type 1 and type 2 diabetes.(1) Type 2 diabetes is the most common type, accounting for an...

2011-07-08 09:42:00

WORCESTER, Mass. and TORONTO, July 8, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (OTC Bulletin Board: GNBT) (www.generex.com) today announced preliminary clinical results of two major trials using the Generex Oral-lyn(TM) formulation that will be used for registration and marketing. Unlike prior reported results from studies using older versions of the formulation, the combined data from the now completed 084 Trial in Type 1 patients and the Prevoral Trial in patients with...

2011-07-07 09:46:00

ORLANDO, Fla., July 7, 2011 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and the advocacy organization Children with Diabetes, Inc. (CWD) today announced a two-year partnership to develop and distribute resources that will help newly diagnosed children with type 1 diabetes adjust to their new lifestyle. Every year, approximately 15,600 children and adolescents in the United States are diagnosed with type 1 diabetes, a condition that occurs when the body does not produce...

2011-06-28 11:30:00

ROCKVILLE, Md., June 28, 2011 /PRNewswire/ -- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of teplizumab in type 1 diabetes. Exploratory, post-hoc analyses suggest that teplizumab, an anti-CD3 monoclonal antibody, when used in a 14-day full dose regimen, preserves C-peptide and increases the...

2011-06-28 07:31:23

(Ivanhoe Newswire) -- A major international study collating and analyzing worldwide data on diabetes since 1980 has found that the number of adults with the disease reached 347 million in 2008, more than double the number in 1980. The research shows that the prevalence of diabetes has risen or at best remained unchanged in virtually every part of the world over the last three decades. Diabetes occurs when the cells of the body are not able to take up sugar in the form of glucose. As a...

2011-06-27 09:24:00

ROCKVILLE, Md., June 27, 2011 /PRNewswire-USNewswire/ -- Results of two studies testing drugs to slow or stop the immune system's attack on insulin-producing cells in people newly diagnosed with type 1 diabetes will be presented at the American Diabetes Association's (ADA) 71st Scientific Sessions in San Diego and simultaneously published online in the Lancet. The studies were conducted by the National Institutes of Health's international network of researchers, Type 1 Diabetes TrialNet...

2011-06-27 12:25:29

The life expectancy of people diagnosed with type 1 diabetes dramatically increased during the course of a 30-year, long-term prospective study, according to a University of Pittsburgh Graduate School of Public Health study being presented at the 71st Scientific Sessions of the American Diabetes Association. The life expectancy for participants diagnosed with type 1 diabetes between 1965 and 1980 was 68.8 years "“ a 15-year improvement, compared to those diagnosed between 1950 and 1964,...

ccd72bdaf77a1ba39fc530ae9c0e061a
2011-06-26 07:25:00

A major international study recently found that diabetes cases have more than doubled to 347 million cases since 1980, a number far larger than what experts previously thought and one that suggests costs of treating the disease will also skyrocket. The research, published in the journal "ËœThe Lancet,' reveals that from 1980 to 2008, diabetes has either risen or gone unchanged in every region of the world. The estimated number of diabetics is much higher than a previous projection...

2011-06-24 16:00:00

LA JOLLA, Calif., June 24, 2011 /PRNewswire/ -- Cebix Incorporated announced today that preclinical data for its long-acting form of C-peptide, Ersatta(TM) (CBX129801), demonstrated a half-life of three days as compared to one hour for native C-peptide. Ersatta halted the impairment in nerve conduction velocity, a measure of the rate at which electrical signals travel through the nerves, in an animal model of diabetic peripheral neuropathy. Additionally, clinical data showed that native...

2011-06-22 14:57:00

Concerns about progress, patient access voiced at Senate hearing for JDRF's Children's Congress WASHINGTON, June 22, 2011 /PRNewswire-USNewswire/ -- Kevin Kline and four children with type 1 diabetes urged the Food and Drug Administration (FDA) to take immediate action to accelerate the research and review of artificial pancreas systems at a hearing before the Senate Committee on Homeland Security and Government Affairs. The hearing, "Transforming Lives through Diabetes Research," was...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.